Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac
Event:
Heart Failure 2023
Topic:
Heart Failure with Reduced Ejection Fraction (HFrEF)
Session:
Heart failure with reduced ejection fraction (HFrEF) 2